Participants were randomly assigned to receive either asundexian (50 mg once daily) or apixaban (5 mg twice daily, or 2.5 mg twice daily for those meeting two or more dose reduction criteria).

The OCEANIC-AF trial randomized patients to either the novel factor XIa inhibitor asundexian 50 mg once daily or apixaban 5 mg or 2.5 mg twice daily ... and 12,317 patients were OAC-experienced (mean ...

During a search of the vehicle, officers seized from under Wiegand's seat 74 tablets, or 36.45 grams, of ecstasy, according to the affidavits. In addition to the drug charge, Wiegand is charged ...

For CrCl ≤15 mL/min, CKD stage V, no data available for any of the agents listed. ARISTOTLE indicates Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation; bw, body ...